Bath & Body Works Stock Hits 52-Week Low at $15.43

Bath & Body Works, Inc. has reached a new 52-week low of USD 15.43 as of November 20, 2025. This marks a significant decline for the small-cap company, which operates in the footwear industry. Over the past year, Bath & Body Works has experienced a substantial drop in its stock price, with a performance decline of 65.33%, contrasting sharply with the S&P 500's positive return of 12.26%.
The company's market capitalization stands at USD 6,299 million, and it currently has a price-to-earnings (P/E) ratio of 7.00. However, the financial metrics indicate underlying weaknesses, including a negative book value and a return on equity that is notably low. The dividend yield is reported at 3.49%, but the company has faced challenges in maintaining growth, with net sales decreasing at an annual rate of 8.28% over the last five years.

Additionally, Bath & Body Works has shown consistent underperformance against the S&P 500 over the past three years, further highlighting its current market position. The stock's historical volatility and recent performance metrics suggest a cautious outlook for the company.